首页 | 本学科首页   官方微博 | 高级检索  
检索        

低分子肝素钠治疗慢性阻塞性肺疾病急性加重期的疗效观察
引用本文:冯巍,汪洪波.低分子肝素钠治疗慢性阻塞性肺疾病急性加重期的疗效观察[J].医学理论与实践,2011,24(13):1499-1500.
作者姓名:冯巍  汪洪波
作者单位:江苏省赣榆县人民医院,222100
摘    要:目的:探讨低分子肝素钠在慢性阻塞性肺疾病急性加重期(AECOPD)中的应用。方法:66例AECOPD患者随机分为治疗组与对照组。两组患者均予常规治疗,治疗组患者加用低分子肝素钠5 000U皮下注射,1次/12h,治疗10d后复查患者动脉血气分析和肺功能。结果:与对照组相比,治疗组动脉血气指标明显改善,而且治疗组与对照组治疗后FEV1比较有显著性差异(P<0.05)。结论:慢性阻塞性肺疾病急性发作期加用低分子肝素钠可明显提高临床疗效,可以推广使用。

关 键 词:慢性阻塞性肺疾病  急性加重期  低分子肝素钠

Efficacy of Low Molecular Weight Heparin Treatment of Chronic Obstructive Pulmonary Disease with Acute Exacerbation
FENG Wei,WANG Hongbo.Efficacy of Low Molecular Weight Heparin Treatment of Chronic Obstructive Pulmonary Disease with Acute Exacerbation[J].The Journal of Medical Theory and Practice,2011,24(13):1499-1500.
Authors:FENG Wei  WANG Hongbo
Institution:FENG Wei,WANG Hongbo.The People's Hospital of Ganyu County,Jiangsu Province 222100
Abstract:Objective:To investigate the low molecular weight heparin in patients with chronic obstructive pulmonary disease with acute exacerbation(AECOPD)in the application.Methods:66 patients with AECOPD were randomly divided into treatment group and control group.On the basis of conventional treatment,control group was treated with low molecular weight heparin plus 5 000U subcutaneously every 12 hours.After 10 days'treatment arterial blood gas analysis and pulmonary function were retested.Results:Compared with the ...
Keywords:Chronic obstructive pulmonary disease  Acute exacerbation  Low molecular weight heparin  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号